EUVIMEDEUVIMED entdecken
Crossref

UBE3C promotes pancreatic ductal adenocarcinoma progression by catalysing p53 ubiquitination

Yang Shi, Jiaxi Wang, Qian Cheng, Shuaihui Wu, Xian Qin, Zhiyong Yang

Molecular Biology Reports · 2025

DOI: 10.1007/s11033-025-10751-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Yang Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, 430071, China. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: the talent introduction project of Zhongnan Hospital of Wuhan University, the Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest malignancies worldwide. Ubiquitination is a biological process that regulates the degradation of proteins. Previous studies have indicated that ubiquitin ligase E3C (UBE3C) has procarcinogenic properties in various tumours. Nevertheless, the detailed role of UBE3C in PDAC is still unknown. METHODS AND RESULTS: Bioinformatics analyses of UBE3C were performed, and we found that UBE3C expression was increased in PDAC cells and indicates a poorer clinical prognosis. Moreover, a significant positive correlation existed between UBE3C expression and the number of CD4+ T cells in the tumour microenvironment (TME) of PDAC. CCK-8, colony formation, EdU and flow cytometry assays indicated that UBE3C knockdown promoted apoptosis and inhibited PDAC cell growth, whereas UBE3C overexpression had the opposite effects. Additionally, UBE3C catalysed p53 ubiquitination and promoted pancreatic carcinogenesis by facilitating p53 degradation. This effect was also confirmed in rescue experiments performed with pifithrin-α (PTF-α, an inhibitor of p53). CONCLUSIONS: Our results clarify the importance of UBE3C in PDAC and indicate that the UBE3C-p53 axis may be a novel therapeutic target for PDAC. CLINICAL TRIAL NUMBER: Not applicable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Carcinoma, Pancreatic DuctalPancreatic NeoplasmsUbiquitin-Protein LigasesHumansUbiquitinationCell Line, TumorGene Expression Regulation, NeoplasticCell ProliferationApoptosisDisease ProgressionPrognosisTumor MicroenvironmentMaleMiceFemaleAnimalsMiddle Aged

Stichwörter der Autor:innen

Pancreatic ductal adenocarcinomaUBE3CUbiquitinationp53

Substanzen

Tumor Suppressor Protein p53Ubiquitin-Protein LigasesUBE3C protein, humanTP53 protein, human

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, 430071, China.
  • Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, 430071, China.
  • Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, 430071, China. paulqqqqq@hotmail.com.
  • Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, 430071, China. yangzhiyong@whu.edu.cn.

Förderung

  • the talent introduction project of Zhongnan Hospital of Wuhan University
  • the Natural Science Foundation of Hubei Province

Zitieren

APA

Shi, Y., Wang, J., Cheng, Q., Wu, S., Qin, X., & Yang, Z. (2025). UBE3C promotes pancreatic ductal adenocarcinoma progression by catalysing p53 ubiquitination. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-10751-5

Vancouver

Shi Y, Wang J, Cheng Q, Wu S, Qin X, Yang Z. UBE3C promotes pancreatic ductal adenocarcinoma progression by catalysing p53 ubiquitination. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-10751-5

BibTeX
@article{Shi2025,
  author = {Shi, Yang and Wang, Jiaxi and Cheng, Qian and Wu, Shuaihui and Qin, Xian and Yang, Zhiyong},
  title = {UBE3C promotes pancreatic ductal adenocarcinoma progression by catalysing p53 ubiquitination},
  journal = {Molecular Biology Reports},
  year = {2025},
  doi = {10.1007/s11033-025-10751-5}
}
Kostenlos starten →